Search Results
You are looking at 1 - 2 of 2 items for
- Author: Jaw-Kang Chang x
- Refine by access: All content x
Search for other papers by Willis K Samson in
Google Scholar
PubMed
Search for other papers by Gina L C Yosten in
Google Scholar
PubMed
Search for other papers by Jaw-Kang Chang in
Google Scholar
PubMed
Search for other papers by Alastair V Ferguson in
Google Scholar
PubMed
Search for other papers by Meghan M White in
Google Scholar
PubMed
Obestatin, a product of post-translational processing of the ghrelin prohormone, has been reported to act in the brain to inhibit thirst. We extended our initial studies on water drinking by examining the effects of obestatin on hypovolemia-induced water and saline drinking and vasopressin release in male rats. Intracerebroventricular administration of obestatin significantly inhibited water, but not saline (0.3 M NaCl) drinking in response to a hypovolemic challenge. Obestatin also inhibited, in a dose-related fashion, dehydration-induced vasopressin secretion without affecting plasma oxytocin levels. Vasopressin release induced by central angiotensin II administration was attenuated significantly by prior administration of obestatin. Finally, central administration of an antiserum specific to obestatin resulted in an exaggerated basal vasopressin release and an increased vasopressin response to overnight water deprivation. Antiserum treatment also resulted in significantly increased ad libitum water drinking and drinking in response to dehydration. We conclude that this product of post-translational processing of the ghrelin prohormone may be an important contributor to the physiologic regulation of fluid and electrolyte homeostasis.
Phoenix Pharmaceuticals Inc., Belmont, California 94002, USA
Search for other papers by Siok L Dun in
Google Scholar
PubMed
Phoenix Pharmaceuticals Inc., Belmont, California 94002, USA
Search for other papers by G Cristina Brailoiu in
Google Scholar
PubMed
Phoenix Pharmaceuticals Inc., Belmont, California 94002, USA
Search for other papers by Eugen Brailoiu in
Google Scholar
PubMed
Phoenix Pharmaceuticals Inc., Belmont, California 94002, USA
Search for other papers by Jun Yang in
Google Scholar
PubMed
Phoenix Pharmaceuticals Inc., Belmont, California 94002, USA
Search for other papers by Jaw Kang Chang in
Google Scholar
PubMed
Phoenix Pharmaceuticals Inc., Belmont, California 94002, USA
Search for other papers by Nae J Dun in
Google Scholar
PubMed
Obestatin, a 23 amino acid peptide recently isolated from the rat stomach, is encoded by the same gene that encodes ghrelin. With the use of an antiserum directed against the mouse/rat obestatin, obestatin immunoreactivity (irOBS) was detected in cells of the gastric mucosa, myenteric plexus, and in Leydig cells of the testis in Sprague–Dawley rats. Double labeling the myenteric plexus with obestatin antiserum and choline acetyltransferase (ChAT) antiserum revealed that nearly all irOBS neurons were ChAT positive and vice versa. For comparative purposes, myenteric ganglion cells, cells in the gastric mucosa, and Leydig cells of the testis were shown to be immunoreactive to preproghrelin. The biological activity of obestatin on rat central neurons was assessed by the calcium microfluorimetric Fura-2 method. Obestatin (100 nM) administered to dissociated and cultured rat cerebral cortical neurons elevated cytosolic calcium concentrations [Ca2+]i in a population of cortical neurons. The result provides the first immunohistochemical evidence that obestatin is expressed in cells of the gastric mucosa and myenteric ganglion cells, and also in Leydig cells of the testis; the peptide is biologically active on central neurons.
